Clinical Trial Update: A Study Of PF-04554878 In Patients With Advanced Non-Hematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study of PF-04554878 in patients with advanced non-hematologic malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• PF-04554878

Snippet

Sponsor: Verastem, Inc. | Conditions: Cancer | Phase 1 | Status: COMPLETED